Product Specifications

Key Features

• Multi-Dose Efficiency: The 5 mL vial allows for multiple doses to be drawn from a single container, making it a cost-effective choice for busy clinics performing regular joint injections.

• Extended Duration: Like other triamcinolone suspensions, it provides long-lasting therapeutic effects, often sustained over several weeks from a single injection.

• Preserved Formula: Contains benzyl alcohol (0.99%) as a preservative, which is standard for multi-dose vials to prevent microbial growth during repeated access.

• Liquid Suspension: Consists of micronized powder in liquid form; the product appears as an opaque, milky-white liquid.

• AB-Rated Generic: A therapeutic equivalent to Kenalog®-40, ensuring the same clinical efficacy and safety profile.

Clinical Applications

• Joint Care: Primarily used for intra-articular injection to treat rheumatoid arthritis, osteoarthritis, and acute bursitis.

• Systemic Therapy: Administered deep intramuscularly for severe allergic reactions or dermatologic conditions when oral therapy is insufficient.

• Soft Tissue: Effective for intralesional treatment of keloids and localized inflammatory lesions.

⚠️ Handling Note: As a suspension, the vial must be shaken well before each use to ensure the micronized powder is evenly distributed.

⚠️ Strict Warning: Not for Intravenous (IV) use. The particulate matter in the suspension can cause severe vascular complications if injected into a vein.

⚠️ Safety: Because this is a multi-dose vial, strict aseptic technique must be followed during every withdrawal. Discard the vial according to facility policy (typically 28 days after first puncture) or the manufacturer’s expiration.